首页 | 本学科首页   官方微博 | 高级检索  
检索        

盐酸氨溴索对控制重型颅脑损伤患者肺部感染的临床研究
引用本文:张光强,吴恒刚,张旭春,刘伟国.盐酸氨溴索对控制重型颅脑损伤患者肺部感染的临床研究[J].浙江创伤外科,2004,9(6):357-358.
作者姓名:张光强  吴恒刚  张旭春  刘伟国
作者单位:1. 322118,东阳,浙江省横店集团医院
2. 浙江大学医学院附属第二医院
摘    要:目的探讨盐酸氨溴索对控制重型颅脑损伤患者肺部感染的作用.方法选取GCS3~8分颅脑损伤患者60例,随机分两组,其中30例(治疗组)加用盐酸氨溴索治疗,另30例(对照组)未予盐酸氨溴索.所有患者其他治疗措施均基本相同.结果治疗组肺部感染发生率及死亡率明显低于对照组(P( )0.05).结论盐酸氨溴索对控制重型颅脑损伤患者肺部感染有较好的临床疗效,值得临床推广应用.

关 键 词:重型颅脑损伤  盐酸氨溴索  肺部感染
修稿时间:2003年12月17

Clincal study of mucosolvan on management of lung infection in the patients after severe brain injury
Zhang Guangqiang,Wu Henggang,Zhang Xuchun,et al..Clincal study of mucosolvan on management of lung infection in the patients after severe brain injury[J].Zhejiang Journal of Traumatic Surgery,2004,9(6):357-358.
Authors:Zhang Guangqiang  Wu Henggang  Zhang Xuchun  
Institution:Zhang Guangqiang,Wu Henggang,Zhang Xuchun,et al.The Heng dian Group Hospital,Dongyang,322118,China.
Abstract:Objective To study the effect of Mucosolvan on management of lung infection in the patients after severe brain injury. Method All 60 patients after severe brain injury (Glasgow coma score of 8 or less on admission) were divided into the experimental group and the control group.The experimental group were treated by Mucosolvan and the control group treated without Mucosolvan. Results The results showed that the incidence and death rate of lung infection after severe brain injury in the experimental group were lower than that in the control group(P<0.05). Conclusion The progress of patients with lung infection after severe brain injury can be improved by management with Mucosolvan and it deserves further clinical applications.
Keywords:Severe brain injury  Mucosolvan  Lung infection 
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号